New York bills · 2025 Regular Session
New York A 5099
Adds xylazine to the depressants designated as controlled substances
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Steve Stern (Democratic)
Cosponsors (25)
- Stacey Pheffer Amato (Democratic)
- Marianne Buttenschon (Democratic)
- William Colton (Democratic)
- William Conrad (Democratic/Independence/Working Families)
- Charles Fall (Democratic)
- Billy Jones
- Jen Lunsford (Democratic/Working Families)
- Angelo Santabarbara (Democratic)
- Albert A. Stirpe (Democratic)
- Jo Anne Simon (Democratic)
- Jaime R. Williams (Democratic)
- Edward Ra (Republican)
- Keith Brown (Republican/Conservative/Independence)
- Eric Brown (Republican)
- Kenneth Blankenbush (Republican)
- Jake Ryan Blumencranz (Republican/Conservative)
- Joe DeStefano (Republican/Conservative)
- Jerett Gandolfo (Republican/Conservative/Independence)
- Michael Durso (Republican/Conservative/Independence/Libertarian)
- David McDonough (Republican)
- Scott Gray (Republican)
- Matthew Slater (Republican/Conservative)
- Lester Chang (Republican/Conservative)
- Rebecca Kassay (Democratic)
- Scott H. Bendett (Republican/Conservative)
Summary
Official abstract published by the New York legislature
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO HEALTH - Feb 12, 2025 · House
REFERRED TO HEALTH